References
Kimura N, Capella C, DeLelis RA, Epstein J, Gill A, Kawashima A, et al. (2017) Extra-adrenal paragangliomas In Lloyd RV, Osamura RY, Kloppel G, Rosai J (ed) WHO Classification of Tumors of Endocrine Organs, 4th edn. IARC Press, Lyons, pp190-195.
Kimura N, Shiga K, Kaneko K, Sgisawa C, Katabami T, Naruse M (2020) The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma. Endocr Pathol 31:95-100.
Miettinen M1, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, et al. (2014). GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 38: 13-22.
Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem 239:2910–2917.
Berends AMA, Eisenhofer G, Fishbein L, van der Horst-Schrivers ANA, Kema IP et al. (2019) Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma. Cancers (Basel) 11:1121-1154.
Grouzmann E, Tschopp O, Triponez F, Matter M, Bilz S, Brandle M et al. (2015) Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites? PLoS One 10(5): e0125426.
Isobe, K.; Nakai, T.; Yukimasa, N.; Nanmoku, T.; Takekoshi, K.; Nomura, F (1998) Expression of mRNA coding for four catecholamine synthesizing enzymes in human adrenal pheochromocytomas. Eur J Endocrinol. 138:383–387.
Kimura N, Miura Y, Nagatsu I, Nagura H (1992) Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Pathol Anat Histopathol 421: 25–32.
Kimura N (2017) Update on tumors of adrenal medulla and extra-adrenal paraganglia. AJSP: Reviews & Reports 22: 240–245.
Timmers HJ, Pacak K, Huynh TT, Abu-Asab M, Tsokos M, Merino MJ et al. (2008) Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene. J Clin Endocrinol Metab. 93:4826-32.
Kimura N, Takekoshi K, Horii A, Morimoto R, Imai T, Oki Y et al. (2014) Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma. Endocr Related Cancer 21: L13-6.
Kimura N, Takekoshi K, Naruse M (2018) Risk stratification on pheochromocytoma and paraganglioma from laboratory and clinical medicine. J Clin Med. 7:241-252.
Funding
This study was conducted as a part of the JRAS by a Research Grant from the Japan Agency for Medical Research and Development (AMED) under Grant Number JP19ek010935.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The author declares that they have no conflict of interest.
Ethical Approval
This study was approved by the National Hospital Organization Hakodate Hospital IRB protocol.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kimura, N. Dopamine β-hydroxylase: An Essential and Optimal Immunohistochemical Marker for Pheochromocytoma and Sympathetic Paraganglioma. Endocr Pathol 32, 258–261 (2021). https://doi.org/10.1007/s12022-020-09655-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-020-09655-w